Arbutus Biopharma Corporation ABUS Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's total debt?
- Arbutus Biopharma Corporation (ABUS) reported total debt of $631K in Q1 2026.
- How has Arbutus Biopharma Corporation's total debt changed year-over-year?
- Arbutus Biopharma Corporation's total debt decreased by 46.9% year-over-year, from $1.19M to $631K.
- What is the long-term trend for Arbutus Biopharma Corporation's total debt?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's total debt has grown at a -24.2% compound annual growth rate (CAGR), from $2.98M to $746K.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.